Related Experiment Video

Updated: Aug 11, 2026

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

Modulation of CD4 antigen expression on the lymphocyte surface by immunosuppressive acidic protein in cancer patients

Y Yamaguchi1, E Miyahara, M Funakoshi

  • 1Department of Surgery, Hiroshima University, Japan.

Oncology
|January 1, 1995
PubMed

Insights

Human immunosuppressive acidic protein (IAP) down-regulates CD4+ T-cells, a key immune cell, potentially contributing to immune suppression in cancer patients. This effect was observed in vitro and in vivo.

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • Human immunosuppressive acidic protein (IAP) is implicated in immune regulation.
  • Lymphocyte surface antigens play critical roles in immune cell function and interaction.
  • Cancer-associated immunosuppression can impair anti-tumor immunity.

Purpose of the Study:

  • To investigate the immunomodulatory effects of IAP on lymphocyte surface antigens.
  • To determine the impact of IAP on CD4, CD3, CD8, and T cell receptor alpha-beta expression.
  • To explore the role of IAP in cancer-related immunosuppression.

Main Methods:

  • Flow cytometry analysis of peripheral blood lymphocytes (PBLs).
  • Use of fluorescein-isothiocyanate-labelled antibodies against specific lymphocyte surface antigens.
  • In vitro culture of PBLs with IAP.

Main Results:

  • IAP inhibited lymphocyte responses to phytohemagglutinin in a dose-dependent manner.
  • IAP decreased CD4 and slightly decreased CD3 antigen expression on PBLs.
  • CD4 antigen modulation by IAP was observed in cancer patients and could be induced in vitro.

Conclusions:

  • IAP down-modulates CD4 antigen expression on lymphocytes.
  • This CD4 modulation correlates with increased serum IAP levels in cancer patients.
  • IAP may contribute to cancer-related immunosuppression by down-regulating CD4+ T-cells.

More Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis07:45

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis

Published on: January 26, 2024

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.